EODData

NSE, COHANCE: COHANCE

01 Sep 2025
LAST:

899.2

CHANGE:
 18.60
OPEN:
876.8
HIGH:
906.9
ASK:
0.0
VOLUME:
124.8K
CHG(%):
2.11
PREV:
880.6
LOW:
872.1
BID:
0.0
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
01 Sep 25876.8906.9872.1899.2124.8K
29 Aug 25880.0888.0862.0880.61.17M
28 Aug 25880.3886.7856.3871.7942.9K
27 Aug 25880.9880.9880.9880.90
26 Aug 25902.7908.0879.7880.91.87M
25 Aug 25910.1936.0880.7898.3765.3K
22 Aug 25892.0894.0882.1884.7105.3K
21 Aug 25885.0913.0885.0898.197.6K
20 Aug 25920.0920.0892.0894.8262.6K
19 Aug 25911.5921.1892.8920.4141.6K

COMPANY PROFILE

Name:COHANCE
About:Cohance Lifesciences Limited engage in the end-to-end contract development and manufacturing of intermediates and active pharmaceutical ingredients in India. The coampny offers active pharmaceutical ingredients and formulations for various applications; CDMO services, a flexible and custom solutions for challenging development and manufacturing needs; and clinical, analytical, and research services. It also manufactures finished dosage formulations for pharmaceutical companies; and specialty chemicals, such as electronic chemicals. The company was formerly known as Suven Pharmaceuticals Limited and changed its name to Cohance Lifesciences Limited in May 2025. The company was founded in 1989 and is based in Hyderabad, India. Cohance Lifesciences Limited is a subsidiary of Berhyanda Limited.
Sector:Healthcare
Address:202, B-Wing, Galaxy by Aurobindo Realty, Sy No 83/1, Hyderabad, India, 500081
Website:https://www.cohance.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:99.97
PtB:23.62
PtS:31.91
EBITDA:4.338B
Shares:382.57M
Market Cap:344.004B

TECHNICAL INDICATORS

MA5:882.63
MA10:890.93
MA20:915.72
MA50:974.39
STO9:42.85
STO14:25.46
RSI14:41.70
WPR14:-65.17
MTM14:-42.35
ROC14:-0.05
ATR:31.98
Week High:935.95
Week Low:856.30
Month High:998.30
Month Low:856.30